| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.7M | -13.3% | -25.1% |
| Cost of Revenue | $1.1M | -5.0% | -28.5% |
| Gross Profit | $555K | -26.3% | -17.0% |
| R&D Expense | $816 | -97.3% | -97.7% |
| SG&A Expense | $252K | -12.7% | -12.5% |
| Operating Income | -$232K | -267.6% | +45.9% |
| Net Income | -$226K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.0M | -14.3% | — |
| Accounts Receivable | $926K | +4.5% | — |
| Current Assets | $3.2M | -6.5% | -21.0% |
| Total Assets | $3.3M | -6.0% | -26.3% |
| Current Liabilities | $1.1M | -0.3% | +20.1% |
| Total Liabilities | $1.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$159K | — | — |
| Capital Expenditures | $11K | — | — |
| Investing Cash Flow | -$11K | — | — |
| Financing Cash Flow | -$260K | — | — |
| Free Cash Flow | -$170K | — | — |
| +45.9% |
| EPS (Basic) | -$0.02 | -100.0% | +66.7% |
| EPS (Diluted) | -$0.02 | -100.0% | +66.7% |
| -0.3% |
| -3.7% |
| Stockholders' Equity | $2.2M | -8.5% | -33.7% |